Want to join the conversation?
$RAX said it is selling its Cloud Sites business unit, which is a non-core business. Also, company expects negative impact from the Brexit vote in the UK, where it's seeing somewhat higher churn rates and slowdown in spending among its customers. $RAX expects this to affect its business in 2H of 2016.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.